Skip to main content
Top
Published in: International Journal of Hematology 1/2017

01-01-2017 | Images in Hematology

Chronic NK lymphocytosis identified by a distinct immunophenotypic pattern

Authors: Hae Tha Mya, Yeh Ching Linn, Lay Cheng Lim, Heng Joo Ng

Published in: International Journal of Hematology | Issue 1/2017

Login to get access

Excerpt

We investigated a 55-year-old Chinese female for persistent mild neutropenia. Apart from weight loss of 3 kg over the past year, she was otherwise well with no abnormal physical findings. Full blood count showed white blood cell (WBC) count 5.44 × 109/L, absolute neutrophils 1.8 × 109/L, absolute lymphocyte 3.1 × 109/L, hemoglobin concentration 11.9 g/dL, and platelet count 306 × 109/L. Blood film showed large granular lymphocytes (LGL) (4 %) (Fig. 1a, b). Screening tests for autoimmune disorders, Epstein–Barr virus infection, and HIV infection were negative. Chest X-ray and ultrasound scan of the abdomen were normal, except for stones in the gallbladder.
Literature
1.
go back to reference Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H. WHO classification of tumours of haemopoietic and lymphoid tissues. IRAC: Lyon; 2008. p. 274. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H. WHO classification of tumours of haemopoietic and lymphoid tissues. IRAC: Lyon; 2008. p. 274.
2.
go back to reference Fischer L, Hummel M, Burmeister T, Schwartz S, Thiel E. Skewed expression of natural-killer (NK)-associated antigens on lymphoproliferations of large granular lymphocytes (LGL). Hematol Oncol. 2006;24:78–85.CrossRefPubMed Fischer L, Hummel M, Burmeister T, Schwartz S, Thiel E. Skewed expression of natural-killer (NK)-associated antigens on lymphoproliferations of large granular lymphocytes (LGL). Hematol Oncol. 2006;24:78–85.CrossRefPubMed
Metadata
Title
Chronic NK lymphocytosis identified by a distinct immunophenotypic pattern
Authors
Hae Tha Mya
Yeh Ching Linn
Lay Cheng Lim
Heng Joo Ng
Publication date
01-01-2017
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2017
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-016-2103-2

Other articles of this Issue 1/2017

International Journal of Hematology 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine